Brief: Rallybio Reports Fourth Quarter And Full Year 2021 Financial Results
15/03/2022 12:12
March 15 (Reuters) - Rallybio Corp RLYB.O :
* RALLYBIO REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS
* Q4 LOSS PER SHARE $0.42
* Q4 EARNINGS PER SHARE VIEW $-0.39 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw1L8vP8a
Further company coverage: RLYB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx